Telomir Pharmaceuticals Files 8-K
Ticker: TELO · Form: 8-K · Filed: Feb 20, 2025 · CIK: 1971532
Sentiment: neutral
Topics: corporate-filing, 8-K
Related Tickers: TELO
TL;DR
Telomir Pharma (TELO) filed an 8-K with updated HQ info in Miami.
AI Summary
On February 20, 2025, Telomir Pharmaceuticals, Inc. filed an 8-K report. The filing indicates that the company is located at 100 SE 2nd St, Suite 2000 #1009, Miami, FL 33131, and its principal executive offices are also at this address. The company's telephone number is (786) 396-6723.
Why It Matters
This filing provides updated corporate information for Telomir Pharmaceuticals, Inc., including its principal executive office address and contact number.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not contain significant financial or operational news.
Key Players & Entities
- Telomir Pharmaceuticals, Inc. (company) — Registrant
- Miami, Florida (location) — Principal Executive Offices
- 100 SE 2nd St, Suite 2000 #1009 (address) — Business and Mail Address
- February 20, 2025 (date) — Date of Report
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Telomir Pharmaceuticals, Inc.
In which state was Telomir Pharmaceuticals, Inc. incorporated?
Telomir Pharmaceuticals, Inc. was incorporated in Florida.
What is the Commission File Number for Telomir Pharmaceuticals, Inc.?
The Commission File Number is 001-41952.
What is the IRS Employer Identification Number for Telomir Pharmaceuticals, Inc.?
The IRS Employer Identification Number is 87-2606031.
What is the business address of Telomir Pharmaceuticals, Inc.?
The business address is 100 SE 2nd St, Suite 2000 #1009, Miami, Florida 33131.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 20, 2025 regarding Telomir Pharmaceuticals, Inc. (TELO).